VolitionRx Limited announced that Dr. Jason Terrell tendered written notice of his resignation as Chief Medical Officer, effective as of November 18, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7276 USD | -2.01% | -5.51% | +1.48% |
05-14 | Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024 | |
05-13 | VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.48% | 60.26M | |
-32.63% | 9.2B | |
-5.66% | 3.12B | |
-18.33% | 2.05B | |
-24.39% | 1.59B | |
+65.65% | 1.44B | |
+32.83% | 830M | |
-6.77% | 720M | |
-29.80% | 507M | |
+0.40% | 297M |
- Stock Market
- Equities
- VNRX Stock
- News VolitionRx Limited
- Volitionrx Limited Announces Resignation of Dr. Jason Terrell as Chief Medical Officer